Patent Assignment
Reel/Frame 062795/0601
Merger
Recorded: 2023-02-24
Pages: 4
Assignor
ANTHROGENESIS CORPORATION
Executed: 2017-08-15
Assignee
CLARITY ACQUISITION II LLC
C/O CELULARITY INC. 170 PARK AVE, PATENT DEPT., FLORHAM PARK, NEW JERSEY, 07932
Covered Properties
(35)
Composition for Collecting and Preserving Placental Stem Cells and Methods of Using the Composition
Devices and Methods for Thawing Biological Material
Application:
16/011,599 →
Publication:
US 2019/0152676
Methods of Treating Acute Myeloid Leukemia and Multiple Myeloma Using Natural Killer Cells
Compositions Comprising Human Placental Perfusate Cells, Subpopulations Thereof, and Their Uses
Application:
16/199,116 →
Publication:
US 2019/0117705
Enhanced Placental Stem Cells and Uses Thereof
Treatment of Premature Birth Complications
Application:
16/427,223 →
Publication:
US 2019/0321413
Treatment of Lymphedema and Related Conditions Using Placental Adherent Cells
Application:
16/467,026 →
Publication:
US 2019/0314424
Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using Them
Application:
16/532,080 →
Publication:
US 2020/0009199
Treatment of Pain Using Placental Stem Cells
Use of Placental Stem Cells in Treatment of Acute Kidney Injury
Composition for Collecting and Preserving Placental Stem Cells and Methods of Using the Composition
Application:
16/548,720 →
Publication:
US 2019/0376027
CD34+,CD45- Placental Stem Cell-Enriched Cell Populations
Application:
16/657,428 →
Publication:
US 2020/0048603
Cell Potency Assay
Application:
16/711,086 →
Publication:
US 2020/0363435
Placenta-Derived Adherent Cell Exosomes and Uses Thereof
Patent:
11,173,182 →
Application:
16/740,054 →
Treatment of Inflammatory Diseases Using Placental Stem Cells
Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells
Application:
16/799,818 →
Publication:
US 2020/0188446
Method of Producing Erythrocytes
Application:
16/817,424 →
Publication:
US 2021/0032596
Micro-Organoids, and Methods of Making and Using the Same
Application:
16/854,608 →
Publication:
US 2020/0246385
Natural Killer Cells and Uses Thereof
Application:
16/876,979 →
Publication:
US 2020/0330516
Tumor Suppression Using Human Placenta-Derived Intermediate Natural Killer Cells and Immunomodulatory Compounds
Application:
16/890,716 →
Publication:
US 2021/0121452
Methods of Tissue Generation
Application:
16/909,567 →
Publication:
US 2021/0145872
Extracellular Matrix Composition Beads for Cell Culture
Application:
17/025,124 →
Publication:
US 2021/0002606
Methods for Isolation of Platelets
Application:
17/223,768 →
Publication:
US 2021/0230546
Devices and Methods for Thawing Biological Material
Application:
17/302,353 →
Publication:
US 2021/0253327
Human Placental Collagen Compositions and Methods of Making and Using the Same
Application:
17/302,831 →
Publication:
US 2022/0096352
Methods and Compositions for Treatment of Bone Defects with Placental Cell Populations
Application:
17/302,855 →
Publication:
US 2022/0096564
Cell Composition and Methods of Making the Same
Application:
17/340,979 →
Publication:
US 2021/0289769
Treatment of Diabetic Peripheral Neuropathy Using Placental Cells
Application:
17/455,322 →
Publication:
US 2022/0072063
Placenta-Derived Adherent Cell Exosomes and Uses Thereof
Application:
17/495,985 →
Publication:
US 2022/0241347
Genetically Modified Natural Killer Cells
Application:
17/645,004 →
Publication:
US 2022/0348875
Methods of Generating Natural Killer Cells
Application:
17/733,321 →
Publication:
US 2022/0259563
Enhanced Placental Stem Cells and Uses Thereof
Application:
18/048,291 →
Publication:
US 2023/0081199
Natural Killer Cells and ILC3 Cells and Uses Thereof
Application:
18/056,088 →
Publication:
US 2023/0142803
Treatment of Premature Birth Complications
Application:
18/057,487 →
Publication:
US 2023/0090316
Method of collecting embryonic stem cells
Application:
60/251,900 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 13, 2019
From: ANTHROGENESIS CORPORATION
To: ANTHROGENESIS CORPORATION
Reel/Frame 048319/0336 →
Merger
Feb 13, 2019
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 048319/0609 →
Assignment of Assignor's Interest
Feb 13, 2019
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 049884/0313 →
Assignment of Assignor's Interest
Feb 14, 2019
From: MURPHY, BRIAN
To: ANTHROGENESIS CORPORATION
Reel/Frame 048339/0835 →
Merger
Sep 5, 2019
From: ANTHROGENESIS CORPORATION
To: CLARITY ACQUISITION II LLC
Reel/Frame 050287/0776 →
Assignment of Assignor's Interest
Sep 5, 2019
From: CLARITY ACQUISITION II LLC
To: CELULARITY, INC.
Reel/Frame 050309/0405 →
Assignment of Assignor's Interest
Sep 5, 2019
From: EDINGER, JAMES W.; HEIDARAN, MOHAMMAD; HOFGARTNER, WOLFGANG
To: ANTHROGENESIS CORPORATION
Reel/Frame 050287/0766 →
Corrective Assignment to Correct the Property Number 2 (Application No. with Typo) Previously Recorded at Reel: 061479 Frame: 0032. Assignor(S) Hereby Confirms the Assignment.
Feb 2, 2023
From: ABBOTT, STEWART; KARASIEWICZ-MENDEZ, KATHY; ZHANG, XIAOKUI; HARIRI, ROBERT J.
To: CELULARITY INC.
Reel/Frame 062971/0107 →
Assignment of Assignor's Interest
Feb 24, 2023
From: CLARITY ACQUSITION II LLC
To: CELULARITY INC.
Reel/Frame 062852/0750 →
Assignment of Assignor's Interest
Oct 30, 2025
From: CELULARITY INC.
To: CELENIV PTE. LTD.
Reel/Frame 073705/0109 →